ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ATAI ATAI Life Sciences NV

1.93
0.09 (4.89%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
ATAI Life Sciences NV NASDAQ:ATAI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.09 4.89% 1.93 1.89 1.93 1.9425 1.825 1.85 875,481 22:58:06

Report of Foreign Issuer (6-k)

21/02/2017 11:11am

Edgar (US Regulatory)


 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 201 7

 

Commission File Number: 001-33910

 

ATA Inc.

 

1/F East Gate, Building No.2, Jian W ai S o H o ,

No.39, Dong S an H uan Z hong Road,

Chao Y ang District, Beijing 100022 , China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F      x  Form 40-F      o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):      o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):      o

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes     o No     x

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A

 

 

 



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

ATA Inc.

 

 

 

By:

/s/ Shelly Jiang

 

Name:

Shelly Jiang

 

Title:

Interim Chief Financial Officer

 

Date: February 21, 2017

 

2



 

TABLE OF CONTENTS

 

Exhibit 99.1 — Press release

 

3


1 Year ATAI Life Sciences NV Chart

1 Year ATAI Life Sciences NV Chart

1 Month ATAI Life Sciences NV Chart

1 Month ATAI Life Sciences NV Chart

Your Recent History

Delayed Upgrade Clock